COALESCE Study

The Cooperative Assessment of Late Effects for SCD Curative Therapies (COALESCE) study is a multi-site collaborative effort based at the Vanderbilt Center for Excellence in Sickle Cell Disease with partners at Children's National Hospital, Johns Hopkins University, and the National Institutes of Health. Our goal is to gain a better understanding of long-term health outcomes after curative therapies in both children and adults with sickle cell disease. We are committed to engaging persons and families with sickle cell disease to understand what health outcomes are of greatest importance to them. This information will help to develop a more personalized approach to curative therapies.

On October 2, 2021, we held our inaugural conference dedicated to bringing together members of the sickle cell community and doctors studying and treating sickle cell disease. Video clips from that conference can be found here.

More information about COALESCE is at https://www.coalescestudy.com/